292 related articles for article (PubMed ID: 23043592)
21. Physical properties and compact analysis of commonly used direct compression binders.
Zhang Y; Law Y; Chakrabarti S
AAPS PharmSciTech; 2003 Dec; 4(4):E62. PubMed ID: 15198557
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of dibutyrylchitin as new excipient for sustained drug release.
Casettari L; Cespi M; Castagnino E
Drug Dev Ind Pharm; 2012 Aug; 38(8):979-84. PubMed ID: 22124336
[TBL] [Abstract][Full Text] [Related]
23. Roller compaction of moist pharmaceutical powders.
Wu CY; Hung WL; Miguélez-Morán AM; Gururajan B; Seville JP
Int J Pharm; 2010 May; 391(1-2):90-7. PubMed ID: 20176096
[TBL] [Abstract][Full Text] [Related]
24. Investigating the effects of excipients on the powder flow characteristics of theophylline anhydrous powder formulations.
Nagel KM; Peck GE
Drug Dev Ind Pharm; 2003 Mar; 29(3):277-87. PubMed ID: 12741609
[TBL] [Abstract][Full Text] [Related]
25. [Theoretical modeling and experimental research on direct compaction characteristics of multi-component pharmaceutical powders based on the Kawakita equation].
Si GN; Chen L; Li BG
Yao Xue Xue Bao; 2014 Apr; 49(4):550-7. PubMed ID: 24974476
[TBL] [Abstract][Full Text] [Related]
26. Rapid formulation screening with a Multipart Microscale Fluid bed Powder processor.
Kivikero N; Murtomaa M; Antikainen O; Hatara J; Juppo AM; Sandler N
Pharm Dev Technol; 2011 Aug; 16(4):358-66. PubMed ID: 20387990
[TBL] [Abstract][Full Text] [Related]
27. A mechanistic study on tablet ejection force and its sensitivity to lubrication for pharmaceutical powders.
Uzondu B; Leung LY; Mao C; Yang CY
Int J Pharm; 2018 May; 543(1-2):234-244. PubMed ID: 29621552
[TBL] [Abstract][Full Text] [Related]
28. Pharmaceutical excipients properties and screw feeder performance in continuous processing lines: a Quality by Design (QbD) approach.
Santos B; Carmo F; Schlindwein W; Muirhead G; Rodrigues C; Cabral L; Westrup J; Pitt K
Drug Dev Ind Pharm; 2018 Dec; 44(12):2089-2097. PubMed ID: 30113219
[TBL] [Abstract][Full Text] [Related]
29. Toward better understanding of powder avalanching and shear cell parameters of drug-excipient blends to design minimal weight variability into pharmaceutical capsules.
Nalluri VR; Puchkov M; Kuentz M
Int J Pharm; 2013 Feb; 442(1-2):49-56. PubMed ID: 22917747
[TBL] [Abstract][Full Text] [Related]
30. Flow, packing and compaction properties of novel coprocessed multifunctional directly compressible excipients prepared from tapioca starch and mannitol.
Adeoye O; Alebiowu G
Pharm Dev Technol; 2014 Dec; 19(8):901-10. PubMed ID: 24089696
[TBL] [Abstract][Full Text] [Related]
31. Inverse gas chromatography: considerations about appropriate use for amorphous and crystalline powders.
Planinsek O; Buckton G
J Pharm Sci; 2003 Jun; 92(6):1286-94. PubMed ID: 12761817
[TBL] [Abstract][Full Text] [Related]
32. Effect of moisture and magnesium stearate concentration on flow properties of cohesive granular materials.
Faqih AM; Mehrotra A; Hammond SV; Muzzio FJ
Int J Pharm; 2007 May; 336(2):338-45. PubMed ID: 17289312
[TBL] [Abstract][Full Text] [Related]
33. Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.
Zhou QT; Armstrong B; Larson I; Stewart PJ; Morton DA
Eur J Pharm Sci; 2010 Aug; 40(5):412-21. PubMed ID: 20433919
[TBL] [Abstract][Full Text] [Related]
34. Comparative evaluation of powder and tableting properties of low and high degree of polymerization cellulose I and cellulose II excipients.
de la Luz Reus Medina M; Kumar V
Int J Pharm; 2007 Jun; 337(1-2):202-9. PubMed ID: 17376616
[TBL] [Abstract][Full Text] [Related]
35. On the mechanism of colloidal silica action to improve flow properties of pharmaceutical excipients.
Tran DT; Majerová D; Veselý M; Kulaviak L; Ruzicka MC; Zámostný P
Int J Pharm; 2019 Feb; 556():383-394. PubMed ID: 30529657
[TBL] [Abstract][Full Text] [Related]
36. The effect of the physical states of binders on high-shear wet granulation and granule properties: a mechanistic approach toward understanding high-shear wet granulation process. Part II. Granulation and granule properties.
Li J; Tao L; Dali M; Buckley D; Gao J; Hubert M
J Pharm Sci; 2011 Jan; 100(1):294-310. PubMed ID: 20575062
[TBL] [Abstract][Full Text] [Related]
37. Entrainment of lactose inhalation powders: a study using laser diffraction.
Watling CP; Elliott JA; Cameron RE
Eur J Pharm Sci; 2010 Jul; 40(4):352-8. PubMed ID: 20417708
[TBL] [Abstract][Full Text] [Related]
38. Kinetic energy density and agglomerate abrasion rate during blending of agglomerates into powders.
Willemsz TA; Hooijmaijers R; Rubingh CM; Tran TN; Frijlink HW; Vromans H; van der Voort Maarschalk K
Eur J Pharm Sci; 2012 Jan; 45(1-2):211-5. PubMed ID: 22127372
[TBL] [Abstract][Full Text] [Related]
39. Influence of binder droplet dimension on granulation rate during fluidized bed granulation.
Fujiwara M; Dohi M; Otsuka T; Yamashita K; Sako K
Chem Pharm Bull (Tokyo); 2013; 61(3):320-5. PubMed ID: 23449201
[TBL] [Abstract][Full Text] [Related]
40. Flow rate and flow equation of pharmaceutical free-flowable powder excipients.
Sklubalová Z; Zatloukal Z
Pharm Dev Technol; 2013 Feb; 18(1):106-11. PubMed ID: 22149908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
